Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Boehringer, Sanofi Enter Strategic Contract Mfg. Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Boehringer, Sanofi Enter Strategic Contract Mfg. Pact

Sanofi gains access to capabilities to transfer and manufacture biologics

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Boehringer Ingelheim and Sanofi have entered an alliance to extend Sanofi’s manufacturing capacity network for therapeutic monoclonal antibodies. Boehringer’s cell culture operations will provide contract manufacturing capacities to support the production of Sanofi’s biologics pipeline.

Under the agreement, Sanofi will have access to Boehringer’s capabilities to transfer and manufacture therapeutic monoclonal antibodies for global market supply. Initial product transfers will begin in early 2015.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics